Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Idogen AB | 666,797 | net | 16 Jan 2023 | tx 11+666,797 |
| Elicera Therapeutics AB | 59,336 | net | 11 Mar 2025 | tx 5+59,336 |
| Mendus AB | 31,245 | net | 21 Dec 2017 | tx 1+31,245 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 27,027 | 1.85 SEK | first after silence |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 4,518 | 16.20 SEK | first after silence |
| 16 Jan 2023 | PURCHASE | Idogen AB | 471,771 | 0.20 SEK | |
| 11 Feb 2022 | PURCHASE | Idogen AB | 32,560 | 3.06 SEK | deriv |
| 05 Oct 2021 | PURCHASE | Idogen AB | 19,859 | 2.06 SEK | |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 12,791 | 4.30 SEK | |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 7,500 | 0.00 SEK | deriv |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 7,500 | 8.00 SEK | |
| 01 Dec 2020 | PURCHASE | Idogen AB | 19,859 | 3.75 SEK | |
| 16 Mar 2020 | PURCHASE | Idogen AB | 51,620 | 0.60 SEK | first after silence |
| 16 Mar 2020 | PURCHASE | Idogen AB | 40,442 | 0.60 SEK | |
| 05 Dec 2018 | PURCHASE | Idogen AB | 25,275 | 1.75 SEK | |
| 28 Dec 2017 | PURCHASE | Idogen AB | 1,500 | 4.63 SEK | |
| 28 Dec 2017 | PURCHASE | Idogen AB | 2,000 | 0.27 SEK | anomaly |
| 28 Dec 2017 | PURCHASE | Idogen AB | 1,000 | 0.62 SEK | anomaly |
| 21 Dec 2017 | PURCHASE | Mendus AB | 31,245 | 8.00 SEK | |
| 12 Jun 2017 | PURCHASE | Idogen AB | 911 | 42.00 SEK |
3 purchases reported after at least 12 months of silence — most recent on 11 Mar 2025.